S100P is highly expressed in multiple tumor types, particularly in pancreatic, breast, colorectal, and lung adenocarcinomas, where its expression correlates with cancer invasiveness and metastasis (Cong et al. 2020; Ahmed et al. 2023; Hsu et al. 2015). Here, S100P is linked to lung adenocarcinoma.